Maxcyte (MXCT) Total Non-Current Liabilities (2020 - 2026)
Maxcyte (MXCT) posted quarterly Total Non-Current Liabilities of $26.3 million for Q1 2026, down 13.06% year-over-year from $30.3 million in Q1 2025, and down 14.4% quarter-over-quarter from $30.8 million in Q4 2025.
Maxcyte (MXCT) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Total Non-Current Liabilities for 7 consecutive years, with $26.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 13.06% year-over-year to $26.3 million; the TTM figure through Mar 2026 stood at $26.3 million (down 13.06% YoY), while the FY2025 annual figure was $30.8 million, down 6.65% from the prior year.
- Total Non-Current Liabilities eased to $26.3 million in Q1 2026 per MXCT's latest filing, from $30.8 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $35.8 million in Q4 2023 and bottomed at $26.3 million in Q1 2026.
- Historically, Total Non-Current Liabilities has averaged $31.2 million across 5 years, with a median of $31.3 million in 2022.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 144.74% — and 2026, when it dropped 13.06%.
- Maxcyte's Total Non-Current Liabilities stood at $31.4 million in 2022, then climbed by 14.22% to $35.8 million in 2023, then dropped by 8.04% to $32.9 million in 2024, then dropped by 6.65% to $30.8 million in 2025, then retreated by 14.4% to $26.3 million in 2026.
- Business Quant data shows MXCT's Total Non-Current Liabilities at $26.3 million in Q1 2026, $30.8 million in Q4 2025, and $33.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.37 Bn | 193.76 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.75 Bn | 124.27 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.07 Bn | 109.85 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.64 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.90 Bn | 31.79 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.38 Bn | 23.06 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Maxcyte | 147.42 Mn | 147.42 Mn | 5.60 Mn | 25.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.62 Mn |
| Mar 31, 2026 | 26.33 Mn |
| Dec 31, 2025 | 30.75 Mn |
| Sep 30, 2025 | 32.97 Mn |
| Jun 30, 2025 | 29.00 Mn |
| Mar 31, 2025 | 30.28 Mn |
| Dec 31, 2024 | 32.95 Mn |
| Sep 30, 2024 | 35.03 Mn |
| Jun 30, 2024 | 29.93 Mn |
| Mar 31, 2024 | 31.29 Mn |
| Dec 31, 2023 | 35.82 Mn |
| Sep 30, 2023 | 32.03 Mn |
| Jun 30, 2023 | 28.91 Mn |
| Mar 31, 2023 | 32.42 Mn |
| Dec 31, 2022 | 31.37 Mn |
| Jun 30, 2022 | 32.16 Mn |
| Mar 31, 2022 | 28.32 Mn |
| Dec 31, 2021 | 20.77 Mn |
| Sep 30, 2021 | 13.08 Mn |
| Jun 30, 2021 | 13.14 Mn |